Neal Fowler

Mr. Neal F.
Fowler is an Independent Director at Emergent BioSolutions, Inc., a Chairman at NC Life Sciences Organization, a Chief Executive Officer & Director at Pathalys Pharma, Inc. and an Operating Partner at Catalys Pacific LLC.
He is on the Board of Directors at Emergent BioSolutions, Inc., Pathalys Pharma, Inc. and The North Carolina Biotechnology Center.
Mr. Fowler was previously employed as a Chief Executive Officer & Director by Liquidia Corp., a Chief Executive Officer & Director by Envisia Therapeutics, Inc., an Independent Director by Aralez Pharmaceuticals, Inc., an Independent Director by POZEN, Inc., a President by Liquidia Technologies, Inc., a President by Centocor, Inc., a President by Ortho-mcneil Neurologics, Inc., a Vice President by Ortho-McNeil Pharmaceutical, Inc., a Director-Sales & Marketing by Eli Lilly & Co., a President by Johnson & Johnson, and a Chairman by Unc Eshelman School of Pharmacy Foundation.
He received his undergraduate degree from the University of North Carolina at Chapel Hill and an MBA from the University of North Carolina at Chapel Hill.